Original Article

You have full text access to this OnlineOpen article

Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer†‡§

A randomized prospective trial

  1. David Spiegel MD1,¶,‖,*,
  2. Lisa D. Butler PhD1,¶,
  3. Janine Giese-Davis PhD1,¶,
  4. Cheryl Koopman PhD1,¶,
  5. Elaine Miller RN, MPH1,¶,
  6. Sue DiMiceli BA2,¶,
  7. Catherine C. Classen PhD3,¶,
  8. Patricia Fobair LCSW, MPH4,¶,
  9. Robert W. Carlson MD5,¶,
  10. Helena C. Kraemer PhD1,¶

Article first published online: 23 JUL 2007

DOI: 10.1002/cncr.22890

Issue

Cancer

Cancer

Volume 110, Issue 5, pages 1130–1138, 1 September 2007

Additional Information

How to Cite

Spiegel, D., Butler, L. D., Giese-Davis, J., Koopman, C., Miller, E., DiMiceli, S., Classen, C. C., Fobair, P., Carlson, R. W. and Kraemer, H. C. (2007), Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer. Cancer, 110: 1130–1138. doi: 10.1002/cncr.22890

Author Information

  1. 1

    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California

  2. 2

    SoluGenics LLC, Palo Alto, California

  3. 3

    Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada

  4. 4

    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California

  5. 5

    Department of Medicine/Oncology, Stanford University School of Medicine, Stanford, California

  1. The authors of this article contributed as follows: Dr. Spiegel had full access to all data in the study and takes responsibility for data integrity and data analysis accuracy; Study concept and design: Spiegel, Fobair, Carlson, Kraemer; Data acquisition: Spiegel, Butler, Giese-Davis, Miller, Classen, Fobair; Data analysis and interpretation: Spiegel, Giese-Davis, Butler, Koopman, DiMiceli, Carlson, Kraemer; Drafting of the manuscript: Spiegel, Butler, Giese-Davis; Critical revision of the manuscript for important intellectual content: Spiegel, Butler, Giese-Davis, Koopman, Miller, DiMiceli, Classen, Fobair, Carlson; Statistical analysis: Giese-Davis, Butler, Koopman, DiMiceli, Kraemer; Funding acquisition: Spiegel, Butler, Koopman, Giese-Davis; Administrative, technical, or material support: Miller, Carlson; Study supervision: Spiegel, Butler, Koopman, Carlson.

  2. ‖

    Fax: (650) 498-6678

*Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305-5718

  1. †

    The study sponsors had no role in the design and conduct of the study, collection, management, analysis, interpretation of the data, or preparation, review, or approval of the manuscript.

  2. ‡

    ClinicalTrials.gov Identifier: NCT00226928. http://www.clinicaltrials.gov

  3. §

    This article was presented at the annual meeting of the American Psychiatric Association, May 20, 2006, Toronto, Canada.

Publication History

  1. Issue published online: 20 AUG 2007
  2. Article first published online: 23 JUL 2007
  3. Manuscript Accepted: 24 APR 2007
  4. Manuscript Revised: 10 APR 2007
  5. Manuscript Received: 26 FEB 2007

Funded by

  • National Institute for Mental Health. Grant Number: 5R01MH047226
  • National Cancer Institute
  • American Cancer Society. Grant Number: PF-4185
  • The John D. and Catherine T. MacArthur Foundation
  • Fetzer Institute

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (244K)

REFERENCES

  • 1
    Spiegel D, Bloom JR, Yalom I. Group support for patients with metastatic cancer. A randomized outcome study. Arch Gen Psychiatry. 1981; 38: 527–533.
  • 2
    Spiegel D, Bloom JR. Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosom Med. 1983; 45: 333–339.
  • 3
    Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet. 1989; 2: 888–891.
  • 4
    Kogon MM, Biswas A, Pearl D, Carlson RW, Spiegel D. Effects of medical and psychotherapeutic treatment on the survival of women with metastatic breast carcinoma. Cancer. 1997; 80: 225–230.
    Direct Link:
  • 5
    Kuchler T, Henne-Bruns D, Rappat S, et al. Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: survival results of a trial. Hepatogastroenterology. 1999; 46: 322–335.
  • 6
    McCorkle R, Strumpf NE, Nuamah IF, et al. A specialized home care intervention improves survival among older post-surgical cancer patients. J Am Geriatrics Soc. 2000; 48: 1707–1713. Comment in: J Am Geriatr Soc. 2000; 48: 1732–1733.
  • 7
    Fawzy FI, Fawzy NW, Hyun CS, et al. Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry. 1993; 50: 681–689.
  • 8
    Fawzy FI, Canada AL, Fawzy NW. Malignant melanoma: effects of a brief, structured psychiatric intervention on survival and recurrence at 10-year follow-up. Arch Gen Psychiatry. 2003; 60: 100–103.
  • 9
    Richardson JL, Shelton DR, Krailo M, Levine AM. The effect of compliance with treatment on survival among patients with hematologic malignancies. J Clin Oncol. 1990; 8: 356–364.
  • 10
    Linn MW, Linn BS, Harris R. Effects of counseling for late stage cancer. Cancer. 1982; 49: 1048–1055.
    Direct Link:
  • 11
    Ilnyckyj A, Farber J, Cheang M, Weinerman B. A randomized controlled trial of psychotherapeutic intervention in cancer patients. Ann R Coll Phys Surg Can. 1994; 27: 93–96.
  • 12
    Edelman S, Lemon J, Bell DR, Kidman AD. Effects of group CBT on the survival time of patients with metastatic breast cancer. Psychooncology. 1999; 8: 474–481.
    Direct Link:
  • 13
    Cunningham AJ, Edmonds CVI, Jenkins GP, Pollack H, Lockwood GA, Warr D. A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psychooncology. 1998; 7: 508–517.
  • 14
    Goodwin PJ, Leszcz M, Ennis M, et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med. 2001; 345: 1719–1726.
  • 15
    Kissane DW, Love A, Hatton A, et al. Effect of cognitive-existential group therapy on survival in early-stage breast cancer. J Clin Oncol. 2004; 22: 4255–4260.
  • 16
    Spiegel D. Effects of psychotherapy on cancer survival. Nat Rev Cancer. 2002; 2: 383–389.
  • 17
    Newell SA, Sanson-Fisher RW, Savolainen NJ. Systematic review of psychological therapies for cancer patients: overview and recommendations for future research. J Natl Cancer Inst. 2002; 94: 558–584.
  • 18
    Chow E, Tsao MN, Harth T. Does psychosocial intervention improve survival in cancer? A meta-analysis. Palliat Med. 2004; 18: 25–31.
  • 19
    Edwards AG, Hailey S, Maxwell M. Psychological interventions for women with metastatic breast cancer. Cochrane Database Syst Rev. 2004: CD004253. Comment in: Evid Based Nurs. 2004; 7: 110.
  • 20
    Smedslund G, Ringdal GI. Meta-analysis of the effects of psychosocial interventions on survival time in cancer patients. J Psychosom Res. 2004; 57: 123–131; discussion, 133–135.
  • 21
    Spiegel D. Commentary on meta-analysis of the effects of psychosocial interventions on survival time and mortality in cancer patients by Geir Smedslund and Gerd Inger Ringdal. J Psychosom Res. 2004; 57: 133–135.
  • 22
    Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry. 2003; 54: 269–282.
  • 23
    Evans DL, Charney DS, Lewis L, et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry. 2005; 58: 175–189.
  • 24
    Classen C, Butler LD, Koopman C, et al. Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch Gen Psychiatry. 2001; 58: 494–501.
  • 25
    Efron B. Forcing a sequential experiment to be balanced. Biometrika. 1971; 58: 403–417.
  • 26
    Spiegel D, Classen C. Group Therapy for Cancer Patients: A Research-Based Handbook of Psychosocial Care. New York: Basic Books; 2000.
  • 27
    Spiegel H, Spiegel D. Trance and Treatment: Clinical Uses of Hypnosis. Washington, DC: American Psychiatric Publishing; 2004.
  • 28
    Giese-Davis J, Koopman C, Butler LD, et al. Change in emotion-regulation strategy for women with metastatic breast cancer following supportive-expressive group therapy. J Consult Clin Psychol. 2002; 70: 916–925.
  • 29
    Kraemer HC, Robinson TN. Are certain multicenter randomized clinical trial structures misleading clinical and policy decisions? Contemp Clin Trials. 2005; 26: 518–529.
  • 30
    Kraemer HC, Blasey CM. Centering in regression analyses: a strategy to prevent errors in statistical inference. Int J Methods Psychiatr Res. 2004; 13: 141–151.
    Direct Link:
  • 31
    Peto R, Boreham J, Clarke M, Davies C, Beral V. UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years. Lancet. 2000; 355: 1822.
  • 32
    Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 365: 1687–1717. Comments in: ACP J Club. 2005; 143: 58. Lancet. 2005; 365: 1665–1666.
  • 33
    Kraemer HC, Frank E, Kupfer DJ. Moderators of treatment outcomes: clinical, research, and policy importance. JAMA. 2006; 296: 1286–1289.
  • 34
    Kraemer HC, Stice E, Kazdin A, Offord D, Kupfer D. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. Am J Psychiatry. 2001; 158: 848–856.
  • 35
    Kraemer HC. Pitfalls of multisite randomized clinical trials of efficacy and effectiveness. Schizophr Bull. 2000; 26: 533–541.
  • 36
    Yalom ID, Greaves C. Group therapy with the terminally ill. Am J Psychiatry. 1977; 134: 396–400.
  • 37
    Fox BA. A hypothesis about Spiegel et al.'s 1989 paper on psychosocial intervention and breast cancer survival. Psychooncology. 1998; 7: 361–370.
  • 38
    Goodwin PJ, Pritchard KI, Spiegel D. The Fox guarding the clinical trial: internal vs. external validity in randomized studies [letter]. Psychooncology. 1999; 8: 275. Comment in: Psychooncology. 1999; 8: 366–367.
    Direct Link:
  • 39
    Kissane DW, Grabsch B, Clarke DM, et al. Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Psychooncology. 2007; 16: 227–286.
  • 40
    Riggs BL, Hartmann LC. Selective estrogen-receptor modulators – mechanisms of action and application to clinical practice. N Engl J Med. 2003; 348: 618–629.
  • 41
    Smith IE, Dowsett M. Aromatase inhibitors in breast cancer. N Engl J Med. 2003; 348: 2431–2442.
  • 42
    Berry DA, Cirrincione C, Henderson IC, et al. Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA. 2006; 295: 1658–1667.
  • 43
    Chlebowski RT, Blackburn GL, Elashoff RE, et al. Dietary fat reduction in postmenopausal women with primary breast cancer: Phase III Women's Intervention Nutrition Study (WINS) [abstract]. ASCO Meeting Abstracts. 2005; 23: 10.
  • 44
    Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000; 406: 747–752.
  • 45
    Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003; 100: 8418–8423.
  • 46
    Kristensen VN, Sorlie T, Geisler J, et al. Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implications. Clin Cancer Res. 2005; 11(2 pt 2): 878s–883s.
  • 47
    Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001; 98: 10869–10874.
  • 48
    Gore-Felton C, Spiegel D. Enhancing women's lives: the role of support groups among breast cancer patients. J Spec Group Work. 1999; 24: 274–287.
  • 49
    Pohls UG, Renner SP, Fasching PA, et al. Awareness of breast cancer incidence and risk factors among healthy women. Eur J Cancer Prev. 2004; 13: 249–256.
View Full Article (HTML) Get PDF (244K)